VISIOMED GROUP EO 001
Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, Saudi Arabia, and the European Union. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. The company was formerly known as Visiom… Read more
Market Cap & Net Worth: VISIOMED GROUP EO 001 (7V91)
VISIOMED GROUP EO 001 (F:7V91) has a market capitalization of $52.07 Million (€50.73 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #23377 globally and #2552 in its home market, demonstrating a -12.87% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VISIOMED GROUP EO 001's stock price €0.17 by its total outstanding shares 307059327 (307.06 Million).
VISIOMED GROUP EO 001 Market Cap History: 2018 to 2026
VISIOMED GROUP EO 001's market capitalization history from 2018 to 2026. Data shows change from $1.08 Billion to $52.07 Million (-39.77% CAGR).
VISIOMED GROUP EO 001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VISIOMED GROUP EO 001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7V91 by Market Capitalization
Companies near VISIOMED GROUP EO 001 in the global market cap rankings as of March 18, 2026.
Key companies related to VISIOMED GROUP EO 001 by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
VISIOMED GROUP EO 001 Historical Marketcap From 2018 to 2026
Between 2018 and today, VISIOMED GROUP EO 001's market cap moved from $1.08 Billion to $ 52.07 Million, with a yearly change of -39.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €52.07 Million | -19.22% |
| 2025 | €64.46 Million | +31.77% |
| 2024 | €48.92 Million | -39.84% |
| 2023 | €81.32 Million | -35.66% |
| 2022 | €126.39 Million | +365.20% |
| 2021 | €27.17 Million | -90.37% |
| 2020 | €282.09 Million | +30.09% |
| 2019 | €216.85 Million | -80.00% |
| 2018 | €1.08 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of VISIOMED GROUP EO 001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $52.07 Million USD |
| MoneyControl | $52.07 Million USD |
| MarketWatch | $52.07 Million USD |
| marketcap.company | $52.07 Million USD |
| Reuters | $52.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.